# BioPharma US Partners, LP — Form D

BioPharma US Partners, LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2012-02-15. $155.5M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2012-02-15
- Form: D
- Accession: 0001542088-12-000003
- Industry: Pooled Investment Fund
- Exemptions: 06, 3C, 3C.7
- Amount sold: $155.5M
- Investors: 34
- Date of first sale: 2009-06-26
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-173487

## Issuer

- Name: BioPharma US Partners, LP
- CIK: 0001542088
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Phone: 212.883.2296

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Pedro Gonzalez de Cosio | Executive Officer | New York, NY |
| Pablo Legoretta | Executive Officer | New York, NY |
| Benjamin Schliemann | Executive Officer | New York, NY |

## More

- [CIK 1542088 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1542088&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001542088-12-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.